Article
Treatment of chronic hepatitis C in Asia: when East meets West.
Journal of gastroenterology and hepatology - 1 Mar 2009
Yu Ming-Lung, Chuang Wan-Long
Abstract excerpt
The issue of best treatment for chronic hepatitis C virus (HCV) infection is in constant flux, not only in Western countries but also in Asia. Currently, pegylated-interferon plus ribavirin is the standard of care. Studies from Asia provide evidence to support the same broad treatment strategies for Asian patients as recommended in Western countries. Nevertheless, there is increasing evidence that Asians have a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
